Neuroscience-Informed Treatments
This section contains a compilation of recent publications that have shaped the thinking in the field as well as classic works that remain important to the subject reviewed in this issue. This bibliography has been compiled by experts in the field and members of the editorial and advisory boards. Entries are listed chronologically and within topics and years by first author. Articles from the bibliography that are reprinted in this issue are in bold type.
2018
Blumberger DM, Vila-Rodriguez F, Thorpe KE, et al: Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial. Lancet 2018; 391:1683–1692
Borrione L, Moffa AH, Martin D, et al: Transcranial direct current stimulation in the acute depressive episode: a systematic review of current knowledge. J ECT 2018; 34:153–163
Canuso CM, Singh JB, Fedgchin M, et al: Efficacy and safety of intranasal esketamine for the rapid reduction of symptoms of depression and suicidality in patients at imminent risk for suicide: results of a double-blind, randomized, placebo-controlled study. Am J Psychiatry 2018; 175:620–630
Dougherty DD, Brennan BP, Stewart SE, et al: Neuroscientifically informed formulation and treatment planning for patients with obsessive-compulsive disorder: a review. JAMA Psychiatry 2018; 75:1081–1087
Gandal MJ, Haney JR, Parikshak NN, et al: Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap. Science 2018; 359:693–697
Grazioli S, Mauri M, Crippa A, et al: Light up ADHD: II. Neuropharmacological effects measured by near infrared spectroscopy: is there a biomarker? J Affect Disord 2018; 244:100–106
Grunebaum MF, Galfalvy HC, Choo TH, et al: Ketamine for rapid reduction of suicidal thoughts in major depression: a midazolam-controlled randomized clinical trial. Am J Psychiatry 2018; 175:327–335
Loo CK, Husain MM, McDonald WM, et al: International randomized-controlled trial of transcranial direct current stimulation in depression. Brain Stimul 2018; 11:125–133
Martin DM, Moffa A, Nikolin S, et al: Cognitive effects of transcranial direct current stimulation treatment in patients with major depressive disorder: an individual patient data meta-analysis of randomised, sham-controlled trials. Neurosci Biobehav Rev 2018; 90:137–145
Marwood L, Wise T, Perkins AM, et al: Meta-analyses of the neural mechanisms and predictors of response to psychotherapy in depression and anxiety. Neurosci Biobehav Rev 2018; 95:61–72
McClintock SM, Reti IM, Carpenter LL, et al: Consensus recommendations for the clinical application of repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression. J Clin Psychiatry 2018; 79:35–48
Moffa AH, Brunoni AR, Nikolin S, et al: Transcranial direct current stimulation in psychiatric disorders: a comprehensive review. Psychiatr Clin North Am 2018; 41:447–463
Nemeroff CB: Ketamine: quo vadis? Am J Psychiatry 2018; 175:297–299
Pereira LP, Köhler CA, Stubbs B, et al: Imaging genetics paradigms in depression research: systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 2018; 86:102–113
Ryan KM, McLoughlin DM: From molecules to mind: mechanisms of action of electroconvulsive therapy. Acta Psychiatr Scand 2018; 138:177–179
Sanacora G, Katz R: Ketamine: a review for clinicians. Focus 2018; 16:243–250
Sestan N, State MW: Lost in translation: traversing the complex path from genomics to therapeutics in autism spectrum disorder. Neuron 2018; 100:406–423
Short B, Fong J, Galvez V, et al: Side-effects associated with ketamine use in depression: a systematic review. Lancet Psychiatry 2018; 5:65–78
Stevens MC, Pearlson GD, Calhoun VD, et al: Functional neuroimaging evidence for distinct neurobiological pathways in attention-deficit/hyperactivity disorder. Biol Psychiatry Cogn Neurosci Neuroimaging 2018; 3:675–685
Taylor SF, Ho SS, Abagis T, et al: Changes in brain connectivity during a sham-controlled, transcranial magnetic stimulation trial for depression. J Affect Disord 2018; 232:143–151
Tolmeijer E, Kumari V, Peters E, et al: Using fMRI and machine learning to predict symptom improvement following cognitive behavioural therapy for psychosis. Neuroimage Clin 2018; 20:1053–1061
Volkow ND, Boyle M: Neuroscience of addiction: relevance to prevention and treatment. Am J Psychiatry 2018; 175:729–740
2017
Antal A, Alekseichuk I, Bikson M, et al: Low intensity transcranial electric stimulation: safety, ethical, legal regulatory and application guidelines. Clin Neurophysiol 2017; 128:1774–1809
Brunoni AR, Moffa AH, Sampaio-Junior B, et al: Trial of electrical direct-current therapy versus escitalopram for depression. N Engl J Med 2017; 376:2523–2533
Drysdale AT, Grosenick L, Downar J, et al: Resting-state connectivity biomarkers define neurophysiological subtypes of depression. Nat Med 2017; 23:28–38
Ross DA, Arbuckle MR, Travis MJ, et al: An integrated neuroscience perspective on formulation and treatment planning for posttraumatic stress disorder: an educational review. JAMA Psychiatry 2017; 74:407–415
Philip NS, Nelson BG, Frohlich F, et al: Low-intensity transcranial current stimulation in psychiatry. Am J Psychiatry 2017; 174:628–639
Sanacora G, Frye MA, McDonald W, et al: A consensus statement on the use of ketamine in the treatment of mood disorders. JAMA Psychiatry 2017; 74:399–405
Further Reading
Ballard ED, Ionescu DF, Vande Voort JL, et al: Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety. J Psychiatr Res 2014; 58:161–166
Berman RM, Cappiello A, Anand A, et al: Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 2000; 47:351–354
Bikson M, Grossman P, Thomas C, et al: Safety of transcranial direct current stimulation: evidence based update 2016. Brain Stimul 2016; 9:641–661
Brunoni AR, Valiengo L, Baccaro A, et al: The sertraline vs. electrical current therapy for treating depression clinical study: results from a factorial, randomized, controlled trial. JAMA Psychiatry 2013; 70:383–391
Diazgranados N, Ibrahim L, Brutsche NE, et al: A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 2010; 67:793–802
Dichter GS, Felder JN, Petty C, et al: The effects of psychotherapy on neural responses to rewards in major depression. Biol Psychiatry 2009; 66:886–897
Haskett RF: Electroconvulsive therapy’s mechanism of action: neuroendocrine hypotheses. J ECT 2014; 30:107–110
Insel TR, Quirion R: Psychiatry as a clinical neuroscience discipline. JAMA 2005; 294:2221–2224
Jelovac A, Kolshus E, McLoughlin DM: Relapse following successful electroconvulsive therapy for major depression: a meta-analysis. Neuropsychopharmacology 2013; 38:2467–2474
Kellner CH, Greenberg RM, Murrough JW, et al: ECT in treatment-resistant depression. Am J Psychiatry 2012; 169:1238–1244
Kellner CH, Knapp RG, Petrides G, et al: Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry 2006; 63:1337–1344
Kirov G, Ebmeier KP, Scott AI, et al: Quick recovery of orientation after magnetic seizure therapy for major depressive disorder. Br J Psychiatry 2008; 193:152–155
Lebowitz MS, Ahn WK: Emphasizing malleability in the biology of depression: durable effects on perceived agency and prognostic pessimism. Behav Res Ther 2015; 71:125–130
Lisanby SH: Electroconvulsive therapy for depression. N Engl J Med 2007; 357:1939–1945
Lisanby SH, Luber B, Schlaepfer TE, et al: Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject comparison with electroconvulsive therapy. Neuropsychopharmacology 2003; 28:1852–1865
Petrides G, Malur C, Braga RJ, et al: Electroconvulsive therapy augmentation in clozapine-resistant schizophrenia: a prospective, randomized study. Am J Psychiatry 2015; 172:52–58
Semkovska M, McLoughlin DM: Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biol Psychiatry 2010; 68:568–577
Skolnick P, Layer RT, Popik P, et al: Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression. Pharmacopsychiatry 1996; 29:23–26
Zanos P, Moaddel R, Morris PJ, et al: NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature 2016; 533:481–486
Zarate CA Jr, Singh JB, Carlson PJ, et al: A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006; 63:856–864
Information & Authors
Information
Published In
History
Published in print: Winter 2019
Published online: 10 January 2019
Authors
Metrics & Citations
Metrics
Citations
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
View Options
View options
PDF/EPUB
View PDF/EPUBLogin options
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Personal login Institutional Login Open Athens loginNot a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).